Titlebook: Nanomaterial-Based Drug Delivery Systems; Therapeutic and Ther Chandrakantsing V. Pardeshi Book 2023 The Editor(s) (if applicable) and The

indulge

書目名稱Nanomaterial-Based Drug Delivery Systems影響因子(影響力)




書目名稱Nanomaterial-Based Drug Delivery Systems影響因子(影響力)學(xué)科排名




書目名稱Nanomaterial-Based Drug Delivery Systems網(wǎng)絡(luò)公開度




書目名稱Nanomaterial-Based Drug Delivery Systems網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nanomaterial-Based Drug Delivery Systems被引頻次




書目名稱Nanomaterial-Based Drug Delivery Systems被引頻次學(xué)科排名




書目名稱Nanomaterial-Based Drug Delivery Systems年度引用




書目名稱Nanomaterial-Based Drug Delivery Systems年度引用學(xué)科排名




書目名稱Nanomaterial-Based Drug Delivery Systems讀者反饋




書目名稱Nanomaterial-Based Drug Delivery Systems讀者反饋學(xué)科排名

FLEET

ELUC

取之不竭

https://doi.org/10.1007/978-3-031-30529-0nanocarriers; polymer based nano carriers; nanobiotechnology in drug delivery; Regulatory issues in nan

Tinea-Capitis

of nanocarriers.Illustrates the history of discovery and dev.Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis an

monochromatic

火光在搖曳

famine

Theranostic Applications of Quantum Dots,ng, fluorescence, immune assay, and toxicity. In addition, possible challenges have been confronted in the use of QDs in nanoformulations with respect to diagnostic and therapeutic purposes. This chapter aims at presenting the utility of QDs as a class of nanomaterials and their varied theranostic applications in modern medicine.

Protein

A Brief Overview on Theranostic Applications of Graphene and Graphene-Based Nanomaterials,ultifunctional therapeutic platforms in the rapid diagnosis and treatment of different ailments. This chapter covers a comprehensive and structured overview of GBNs, including their discovery and biomedical applications in drug delivery, gene delivery, phototherapy, bioimaging, and as theranostics.

BLUSH

Translating Nanomaterials from Laboratory to Clinic: Barriers Ahead,ntific experts, regulatory bodies, investors, and clinicians are essential to come up with extensive methodologies to make certain reproducibility and specific control for the development of safe, efficient, and robust nanomedicines.